Vogelzang [14]
|
Cisplatin (75mg/m2 on day one)/pemetrexed (500mg/m2 on day one)
|
Every three weeks, 6.0 courses
|
226
|
41 percent
|
12.1
|
Nakano [15]
|
Cisplatin (60mg/m2 on day one)/irinotecan (60mg/m2 on days one, eight, and 15)
|
Every four weeks, 2.6 courses
|
15
|
27 percent
|
6.5
|
Tsavaris [16]
|
Cisplatin (100mg/m2 on day one)/vinblastine (6mg/m2 on days one and eight)
|
Every four weeks, 4.0 courses
|
20
|
25 percent
|
N/A
|
Ardizzoni [17]
|
Cisplatin (60mg/m2 on day 1)/doxorubicin (60mg/m2 on day one)
|
Every three to four weeks, 3.0 to 4.0 courses
|
26
|
25 percent
|
10
|
Nowak [18]
|
Cisplatin (100mg/m2 on day one)/gemcitabine (1000mg/m2 on days one, eight, and 15)
|
Every four weeks, 4.0 courses
|
53
|
33 percent
|
11.2
|
Present report
|
Cisplatin (60mg/m2 on day one)/irinotecan (60mg/m2 on days one, eight, and 15)
|
One course with hyperthermia
| |
Complete response
|
>84
|